Related references
Note: Only part of the references are listed.The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson's disease
Toshiharu Nagatsu et al.
JOURNAL OF NEURAL TRANSMISSION (2023)
Neuromelanin: Its role in the pathogenesis of idiopathic Parkinson's disease and potential as a therapeutic target
Ritoban Mitra et al.
PARKINSONISM & RELATED DISORDERS (2023)
The risk of melanoma with rasagiline compared with other antiparkinsonian medications: A retrospective cohort study in the United States medicare database
Catherine B. Johannes et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2022)
Anticancer Activity of Amantadine and Evaluation of Its Interactions with Selected Cytostatics in Relation to Human Melanoma Cells
Danuta Krasowska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Understanding the role of sunshine vitamin D in Parkinson's disease: A review
Tapan Behl et al.
FRONTIERS IN PHARMACOLOGY (2022)
Examples of Inverse Comorbidity between Cancer and Neurodegenerative Diseases: A Possible Role for Noncoding RNA
Michele Salemi et al.
CELLS (2022)
UVA Radiation, DNA Damage, and Melanoma
Seung-Gi Jin et al.
ACS OMEGA (2022)
Melanocytic Hyperactivation Simulating an Acral Lentiginous Melanoma in a Patient With Parkinson Disease Treated by Levodopa
Saray Porcar Saura et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2021)
Melanoma Risk Factors and Prevention
William W. Dzwierzynski
CLINICS IN PLASTIC SURGERY (2021)
Amantadine Revisited: A Contender for Initial Treatment in Parkinson's Disease?
Sarah Marmol et al.
CNS DRUGS (2021)
Synthetic Porous Melanin
Zofia E. Siwicka et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)
Risk of Nonmelanoma Skin Cancers and Parkinson's Disease-Meta-Analysis and Systematic Review
Danuta Krasowska et al.
CANCERS (2021)
Changes in cytoplasmic and extracellular neuromelanin in human substantia nigra with normal aging
Dmitrii E. Korzhevskii et al.
EUROPEAN JOURNAL OF HISTOCHEMISTRY (2021)
Melanin, the What, the Why and the How: An Introductory Review for Materials Scientists Interested in Flexible and Versatile Polymers
A. Bernardus Mostert
POLYMERS (2021)
Redox Activities of Melanins Investigated by Electrochemical Reverse Engineering: Implications for their Roles in Oxidative Stress
Eunkyoung Kim et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2020)
Spatiotemporal changes in substantia nigra neuromelanin content in Parkinson's disease
Emma Biondetti et al.
BRAIN (2020)
Defining an amyloid link Between Parkinson's disease and melanoma
Dexter N. Dean et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson's disease pathogenesis
Iria Carballo-Carbajal et al.
NATURE COMMUNICATIONS (2019)
Levodopa-induced skin disorders in patients with Parkinson disease: a systematic literature review approach
Anastasia Bougea et al.
ACTA NEUROLOGICA BELGICA (2019)
Photodegradation of Eumelanin and Pheomelanin and Its Pathophysiological Implications
Shosuke Ito et al.
PHOTOCHEMISTRY AND PHOTOBIOLOGY (2018)
Mechanisms and prevention of UV-induced melanoma
Ashley Sample et al.
PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE (2018)
D-tyrosine negatively regulates melanin synthesis by competitively inhibiting tyrosinase activity
Jisu Park et al.
PIGMENT CELL & MELANOMA RESEARCH (2018)
Light-independent pro-inflammatory and pro-oxidant effects of purified human hair melanins on keratinocyte cell cultures
Serena Lembo et al.
EXPERIMENTAL DERMATOLOGY (2017)
Epidemiology of Parkinson's disease
Ole-Bjorn Tysnes et al.
JOURNAL OF NEURAL TRANSMISSION (2017)
Parkinson Disease and Melanoma: Confirming and Reexamining an Association
Lauren A. Dalvin et al.
MAYO CLINIC PROCEEDINGS (2017)
The substantia nigra and ventral tegmental dopaminergic neurons from development to degeneration
YuHong Fu et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2016)
Actylise treatment does not influence nitric oxide metabolites serum level
Anna Horecka et al.
PHARMACOLOGICAL REPORTS (2016)
Signaling Pathways in Melanogenesis
Stacey A. N. D'Mello et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
The melanocyte lineage in development and disease
Richard L. Mort et al.
DEVELOPMENT (2015)
Chemiexcitation of melanin derivatives induces DNA photoproducts long after UV exposure
Sanjay Premi et al.
SCIENCE (2015)
Melanin: a photoprotection for Bacillus thuringiensis based biopesticides
Estibaliz Sansinenea et al.
BIOTECHNOLOGY LETTERS (2015)
Clinicopathological features, vitamin D serological levels and prognosis in cutaneous melanoma of shield-sites: an update
Giovanni Paolino et al.
MEDICAL ONCOLOGY (2015)
The biology of melanocyte and melanocyte stem cell
Ang Li
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2014)
Primary culture of human face skin melanocytes for the study of hyperpigmentation
Jianbing Tang et al.
CYTOTECHNOLOGY (2014)
Neuromelanin of the Human Substantia Nigra: An Update
Fabio A. Zucca et al.
NEUROTOXICITY RESEARCH (2014)
Skin melanocytes: biology and development
Miroslawa Cichorek et al.
POSTEPY DERMATOLOGII I ALERGOLOGII (2013)
Vitamin D and neurology
Eric Thouvenot et al.
PRESSE MEDICALE (2013)
Comparison of oral and transdermal administration of rasagiline mesylate on human melanoma tumor growth in vivo
Susan R. Meier-Davis et al.
CUTANEOUS AND OCULAR TOXICOLOGY (2012)
L-tyrosine and L-dihydroxyphenylalanine as hormone-like regulators of melanocyte functions
Andrzej Slominski et al.
PIGMENT CELL & MELANOMA RESEARCH (2012)
Ultraviolet B radiation differentially modifies catechol-O-methyltransferase activity in keratinocytes and melanoma cells
Sofia Magina et al.
PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE (2012)
Etiology and Pathogenesis of Parkinson's Disease
Anthony H. Schapira et al.
MOVEMENT DISORDERS (2011)
Water Radiolysis: Influence of Oxide Surfaces on H2 Production under Ionizing Radiation
Sophie Le Caer
WATER (2011)
Rasagiline: A novel anti-Parkinsonian monoamine oxidase-B inhibitor with neuroprotective activity
Orly Weinreb et al.
PROGRESS IN NEUROBIOLOGY (2010)
Disparity in Melanoma A Trend Analysis of Melanoma Incidence and Stage at Diagnosis Among Whites, Hispanics, and Blacks in Florida
Shasa Hu et al.
ARCHIVES OF DERMATOLOGY (2009)
Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-pathological variant
Saverio Caini et al.
EUROPEAN JOURNAL OF CANCER (2009)
The particular relationship between Parkinson's disease and malignancy: a focus on skin cancers
Rivka Inzelberg et al.
JOURNAL OF NEURAL TRANSMISSION (2009)
Parkinson's disease, levodopa-use and the risk of melanoma
J-D. Vermeij et al.
PARKINSONISM & RELATED DISORDERS (2009)
Ionizing radiation: how fungi cope, adapt, and exploit with the help of melanin
Ekaterina Dadachova et al.
CURRENT OPINION IN MICROBIOLOGY (2008)
Chemistry of mixed melanogenesis - Pivotal roles of dopaquinone
Shosuke Ito et al.
PHOTOCHEMISTRY AND PHOTOBIOLOGY (2008)
Human hair pigmentation biological aspects
D. J. Tobin
INTERNATIONAL JOURNAL OF COSMETIC SCIENCE (2008)
The protective role of melanin against UV damage in human skin
Michaela Brenner et al.
PHOTOCHEMISTRY AND PHOTOBIOLOGY (2008)
New founder germline mutations of CDKN2A in melanoma-prone families and multiple primary melanoma development in a patient receiving levodopa treatment
Caroline Kannengiesser et al.
GENES CHROMOSOMES & CANCER (2007)
Treatment with levodopa and risk for malignant melanoma
Jorgen H. Olsen et al.
MOVEMENT DISORDERS (2007)
Neuromelanin in human dopamine neurons: Comparison with peripheral melanins and relevance to Parkinson's disease
H Fedorow et al.
PROGRESS IN NEUROBIOLOGY (2005)
Hypersensitivity of dopamine transmission in the rat striatum after treatment with the NMDA receptor antagonist amantadine
M Peeters et al.
BRAIN RESEARCH (2002)
The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease
L Zecca et al.
FEBS LETTERS (2002)
Drug treatment of Parkinson's disease - Time for phase II
B Drukarch et al.
BIOCHEMICAL PHARMACOLOGY (2000)
Share Paper
